Aurora Cannabis (TSE:ACB) Full Year 2025 Results
Key Financial Results
- Revenue: CA$343.3m (up 27% from FY 2024).
- Net income: CA$16.4m (up from CA$55.3m loss in FY 2024).
- Profit margin: 4.8% (up from net loss in FY 2024).
- EPS: CA$0.30 (up from CA$1.28 loss in FY 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Aurora Cannabis EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 89%.
Looking ahead, revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in Canada.
Performance of the Canadian Pharmaceuticals industry.
The company’s shares are down 22% from a week ago.
